Logo image of PX

P10 INC-A (PX) Stock Fundamental Analysis

NYSE:PX - New York Stock Exchange, Inc. - US69376K1060 - Common Stock - Currency: USD

8.91  -0.1 (-1.11%)

After market: 8.97 +0.06 (+0.67%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PX. PX was compared to 232 industry peers in the Capital Markets industry. There are concerns on the financial health of PX while its profitability can be described as average. PX is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

PX had positive earnings in the past year.
In the past year PX had a positive cash flow from operations.
PX had positive earnings in 4 of the past 5 years.
PX had a positive operating cash flow in each of the past 5 years.
PX Yearly Net Income VS EBIT VS OCF VS FCFPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

The Return On Assets of PX (2.07%) is comparable to the rest of the industry.
With a Return On Equity value of 5.44%, PX perfoms like the industry average, outperforming 40.09% of the companies in the same industry.
PX's Return On Invested Capital of 5.47% is fine compared to the rest of the industry. PX outperforms 66.81% of its industry peers.
PX had an Average Return On Invested Capital over the past 3 years of 3.89%. This is below the industry average of 7.85%.
The last Return On Invested Capital (5.47%) for PX is above the 3 year average (3.89%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.07%
ROE 5.44%
ROIC 5.47%
ROA(3y)1.61%
ROA(5y)2.03%
ROE(3y)3.66%
ROE(5y)10.38%
ROIC(3y)3.89%
ROIC(5y)3.42%
PX Yearly ROA, ROE, ROICPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

PX's Profit Margin of 6.11% is on the low side compared to the rest of the industry. PX is outperformed by 67.24% of its industry peers.
PX's Profit Margin has declined in the last couple of years.
PX's Operating Margin of 20.05% is in line compared to the rest of the industry. PX outperforms 40.09% of its industry peers.
PX's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 20.05%
PM (TTM) 6.11%
GM N/A
OM growth 3Y-8.6%
OM growth 5Y-6.43%
PM growth 3Y1.05%
PM growth 5Y-24.96%
GM growth 3YN/A
GM growth 5YN/A
PX Yearly Profit, Operating, Gross MarginsPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for PX has been reduced compared to 1 year ago.
Compared to 5 years ago, PX has more shares outstanding
The debt/assets ratio for PX is higher compared to a year ago.
PX Yearly Shares OutstandingPX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
PX Yearly Total Debt VS Total AssetsPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.33, we must say that PX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of PX (1.33) is better than 60.78% of its industry peers.
The Debt to FCF ratio of PX is 4.50, which is a neutral value as it means it would take PX, 4.50 years of fcf income to pay off all of its debts.
PX has a Debt to FCF ratio of 4.50. This is in the better half of the industry: PX outperforms 67.67% of its industry peers.
PX has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.07, PX perfoms like the industry average, outperforming 46.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 4.5
Altman-Z 1.33
ROIC/WACCN/A
WACCN/A
PX Yearly LT Debt VS Equity VS FCFPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

PX has a Current Ratio of 0.97. This is a bad value and indicates that PX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of PX (0.97) is worse than 60.78% of its industry peers.
A Quick Ratio of 0.97 indicates that PX may have some problems paying its short term obligations.
PX's Quick ratio of 0.97 is in line compared to the rest of the industry. PX outperforms 43.53% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
PX Yearly Current Assets VS Current LiabilitesPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.05% over the past year.
Measured over the past 5 years, PX shows a small growth in Earnings Per Share. The EPS has been growing by 3.62% on average per year.
Looking at the last year, PX shows a quite strong growth in Revenue. The Revenue has grown by 18.92% in the last year.
PX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.86% yearly.
EPS 1Y (TTM)19.05%
EPS 3Y24.75%
EPS 5Y3.62%
EPS Q2Q%-4.76%
Revenue 1Y (TTM)18.92%
Revenue growth 3Y25.35%
Revenue growth 5Y45.86%
Sales Q2Q%2.35%

3.2 Future

PX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.29% yearly.
The Revenue is expected to grow by 10.54% on average over the next years. This is quite good.
EPS Next Y-10.59%
EPS Next 2Y4.09%
EPS Next 3Y9.29%
EPS Next 5YN/A
Revenue Next Year1.34%
Revenue Next 2Y9.02%
Revenue Next 3Y10.54%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PX Yearly Revenue VS EstimatesPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
PX Yearly EPS VS EstimatesPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.91, the valuation of PX can be described as reasonable.
77.59% of the companies in the same industry are more expensive than PX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.35, PX is valued rather cheaply.
The Price/Forward Earnings ratio is 8.14, which indicates a very decent valuation of PX.
83.19% of the companies in the same industry are more expensive than PX, based on the Price/Forward Earnings ratio.
PX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 8.91
Fwd PE 8.14
PX Price Earnings VS Forward Price EarningsPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

PX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PX is cheaper than 78.88% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PX indicates a somewhat cheap valuation: PX is cheaper than 70.26% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.58
EV/EBITDA 15.02
PX Per share dataPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)2.46
EPS Next 2Y4.09%
EPS Next 3Y9.29%

More info and screens

2

5. Dividend

5.1 Amount

PX has a Yearly Dividend Yield of 1.58%. Purely for dividend investing, there may be better candidates out there.
The stock price of PX dropped by -24.87% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
PX's Dividend Yield is slightly below the industry average, which is at 7.87.
Compared to the average S&P500 Dividend Yield of 2.42, PX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.58%

5.2 History

PX has been paying a dividend for at least 10 years, so it has a reliable track record.
PX has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
PX Yearly Dividends per sharePX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

85.62% of the earnings are spent on dividend by PX. This is not a sustainable payout ratio.
DP85.62%
EPS Next 2Y4.09%
EPS Next 3Y9.29%
PX Yearly Income VS Free CF VS DividendPX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M
PX Dividend Payout.PX Dividend Payout, showing the Payout Ratio.PX Dividend Payout.PayoutRetained Earnings

More info and screens

P10 INC-A

NYSE:PX (6/20/2025, 8:04:01 PM)

After market: 8.97 +0.06 (+0.67%)

8.91

-0.1 (-1.11%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)N/A N/A
Inst Owners62.38%
Inst Owner Change16.2%
Ins Owners14.82%
Ins Owner Change10.08%
Market Cap998.99M
Analysts81.54
Price Target15.3 (71.72%)
Short Float %4.57%
Short Ratio4.28
Dividend
Industry RankSector Rank
Dividend Yield 1.58%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP85.62%
Div Incr Years2
Div Non Decr Years2
Ex-Date05-30 2025-05-30 (0.0375)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.78%
Min EPS beat(2)-5.74%
Max EPS beat(2)11.29%
EPS beat(4)3
Avg EPS beat(4)12.11%
Min EPS beat(4)-5.74%
Max EPS beat(4)24.43%
EPS beat(8)6
Avg EPS beat(8)9.47%
EPS beat(12)10
Avg EPS beat(12)7.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.16%
Min Revenue beat(2)-5.43%
Max Revenue beat(2)11.75%
Revenue beat(4)3
Avg Revenue beat(4)4.68%
Min Revenue beat(4)-5.43%
Max Revenue beat(4)11.75%
Revenue beat(8)5
Avg Revenue beat(8)2.41%
Revenue beat(12)9
Avg Revenue beat(12)3.1%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.14%
PT rev (3m)-3.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.84%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 8.91
Fwd PE 8.14
P/S 3.35
P/FCF 12.58
P/OCF 11.71
P/B 2.99
P/tB N/A
EV/EBITDA 15.02
EPS(TTM)1
EY11.22%
EPS(NY)1.09
Fwd EY12.28%
FCF(TTM)0.71
FCFY7.95%
OCF(TTM)0.76
OCFY8.54%
SpS2.66
BVpS2.98
TBVpS-2.35
PEG (NY)N/A
PEG (5Y)2.46
Profitability
Industry RankSector Rank
ROA 2.07%
ROE 5.44%
ROCE 7.89%
ROIC 5.47%
ROICexc 6.07%
ROICexgc 49.14%
OM 20.05%
PM (TTM) 6.11%
GM N/A
FCFM 26.65%
ROA(3y)1.61%
ROA(5y)2.03%
ROE(3y)3.66%
ROE(5y)10.38%
ROIC(3y)3.89%
ROIC(5y)3.42%
ROICexc(3y)4.15%
ROICexc(5y)3.64%
ROICexgc(3y)42.32%
ROICexgc(5y)39%
ROCE(3y)5.62%
ROCE(5y)4.93%
ROICexcg growth 3Y14.25%
ROICexcg growth 5Y7.5%
ROICexc growth 3Y11.21%
ROICexc growth 5Y3.97%
OM growth 3Y-8.6%
OM growth 5Y-6.43%
PM growth 3Y1.05%
PM growth 5Y-24.96%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 4.5
Debt/EBITDA 4.19
Cap/Depr 22.98%
Cap/Sales 1.97%
Interest Coverage 2.6
Cash Conversion 99.93%
Profit Quality 436.25%
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 1.33
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)9.31%
Cap/Depr(5y)5.71%
Cap/Sales(3y)0.97%
Cap/Sales(5y)0.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.05%
EPS 3Y24.75%
EPS 5Y3.62%
EPS Q2Q%-4.76%
EPS Next Y-10.59%
EPS Next 2Y4.09%
EPS Next 3Y9.29%
EPS Next 5YN/A
Revenue 1Y (TTM)18.92%
Revenue growth 3Y25.35%
Revenue growth 5Y45.86%
Sales Q2Q%2.35%
Revenue Next Year1.34%
Revenue Next 2Y9.02%
Revenue Next 3Y10.54%
Revenue Next 5YN/A
EBIT growth 1Y112.31%
EBIT growth 3Y14.58%
EBIT growth 5Y36.48%
EBIT Next Year-1.78%
EBIT Next 3Y10.91%
EBIT Next 5YN/A
FCF growth 1Y8.44%
FCF growth 3Y25.32%
FCF growth 5Y41.79%
OCF growth 1Y13.95%
OCF growth 3Y27.23%
OCF growth 5Y43.11%